...
首页> 外文期刊>Polyhedron: The International Journal for Inorganic and Organometallic Chemistry >Palladium(II) and platinum(II) oxamate complexes as potential anticancer agents: Structural characterization and cytotoxic activity
【24h】

Palladium(II) and platinum(II) oxamate complexes as potential anticancer agents: Structural characterization and cytotoxic activity

机译:草酸钯(II)和草酸铂(II)复合物作为潜在的抗癌药:结构表征和细胞毒性活性

获取原文
获取原文并翻译 | 示例
           

摘要

The cytotoxic activity against human carcinogenic cells of five compounds, three of them containing palladium(II) and one containing platinum(II) was evaluated for the first time. These compounds were synthesized and characterized and present the formula K_2(H_2opba)?2H_2O (1), K_2[Pd(opba)]?2H_2O (2), [Pd(NH_3)_4]Cl_2?2H_2O (3), [Pd(NH_3)_4][Pd(opba)] (4) and [Pt(H_2opba)]?H_2O (5), where opba = 1,2-phenylenebis(oxamate). Compounds 4 and 5 are novel and their synthesis and characterization are discussed in detail in this paper. The crystal structure of 4 was elucidated by single crystal X-ray diffraction and consists of discrete [Pd(NH_3)_4]~(2+)cations interacting via hydrogen-bonds with [Pd(opba)]~(2-) anions. Despite the fact that compound 1 has no significant effect on the growth of chronic myelogenous leukemia cells, its Pd~(II) and Pt~(II) complexes inhibit cellular growth in the following order of activity 2 ~ 4 > 5. Compounds 2 and 4 are approximately 20 times more cytotoxic against leukemia cells than the free ligand.
机译:首次评估了五种化合物对人类致癌细胞的细胞毒活性,其中三种含有钯(Ⅱ),一种含有铂(Ⅱ)。这些化合物经过合成和表征,其化学式为K_2(H_2opba)→2H_2O(1),K_2 [Pd(opba)]→2H_2O(2),[Pd(NH_3)_4] Cl_2→2H_2O(3),[Pd( NH_3)_4] [Pd(opba)](4)和[Pt(H_2opba)]?H_2O(5),其中opba = 1,2-亚苯基双(草酸酯)。化合物4和5是新颖的,本文详细讨论了它们的合成和表征。通过单晶X射线衍射阐明了4的晶体结构,其由离散的[Pd(NH_3)_4]〜(2+)阳离子通过氢键与[Pd(opba)]〜(2-)阴离子相互作用而组成。尽管化合物1对慢性粒细胞白血病细胞的生长没有显着影响,但其Pd〜(II)和Pt〜(II)配合物以下列活性2〜4> 5的顺序抑制细胞生长。 4对白血病细胞的细胞毒性比游离配体高约20倍。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号